| Date | Time | Source | Announcement |
|---|---|---|---|
| 28 Dec 2001 | 05:42 PM | Interim Results | |
| 02 Nov 2001 | 04:05 PM | Redenomination to Euro | |
| 25 Oct 2001 | 12:00 PM | Re; Negotiations | |
| 10 Sep 2001 | 03:34 PM | Preliminary Results 28/2/01 | |
| 27 Jun 2001 | 04:04 PM | Appointment | |
| 08 Jun 2001 | 12:53 PM | Placing of New Shares | |
| 17 Jan 2001 | 07:30 AM | Proposed Joint Venture | |
| 02 Jan 2001 | 08:26 AM | Interim Results | |
| 26 Oct 2000 | 02:45 PM | AGM Statement | |
| 25 May 2000 | 02:29 PM | Brochure of Particulars | |
| 06 Jan 2000 | 11:40 AM | Directors' Dealings | |
| 29 Dec 1999 | 03:39 PM | Interim Results - 6 Months to 31 August 1999 | |
| 21 Dec 1999 | 08:05 AM | Drilling Programme Centred on West-Limerick | |
| 28 Oct 1999 | 05:29 PM | Resolutions Passed at AGM | |
| 04 Oct 1999 | 06:31 PM | Directors' Dealings | |
| 30 Sep 1999 | 05:57 PM | Directors' Dealings | |
| 28 Sep 1999 | 04:13 PM | Directors' Dealings | |
| 03 Sep 1999 | 10:59 AM | Circ re Notice of AGM | |
| 02 Sep 1999 | 08:36 AM | Doc re Report and Accounts |
Ovoca Bio PLC is a biopharmaceutical company focused on women's health, specifically developing novel treatments for female sexual dysfunction. Their lead product, Orenetide (BP-101), is a synthetic peptide administered via nasal spray, designed to treat hypoactive sexual desire disorder in premenopausal women. The company is incorporated in Ireland and operates in Ireland, the UK, and Russia. It is listed in London under the ticker OVB.
OVB share price was suspended from AIM on 7 May 2025.